Projets des leaders émergents

The Salim Yusuf Emerging Leaders Programme was created by the World Heart Federation to form and develop a long-term cadre of experts who collaborate, research, and act to reduce premature mortality from cardiovascular disease (CVD) globally.
15 Projects
39 Countries
119 Emerging Leaders

Moniteur BP-HOME

Pression artérielle élevée 8 Team Members Spanning 6 countries

The BP-Home Monitor project aims to assess the barriers, facilitators and context for home blood pressure (BP) management in low- and middle-income countries.

En savoir plus

CARDIOMAPPS

Prévention secondaire 7 Team Members Spanning 7 countries

The CARDIOMAPPS project aims to identify obstacles and facilitators of the use of evidence-supported medications for the secondary prevention of CVD.

En savoir plus

CLUBMEDS

Accès aux médicaments essentiels 8 Team Members Spanning 5 countries

An Emerging Leaders project focused on improving access to and adherence to essential cardiovascular medicines in low-resource settings.

En savoir plus

FACILE

Accident vasculaire cérébral 7 Team Members Spanning 6 countries

Une étude prospective, multicentrique, avant et après, à l'initiative de l'investigateur, en aveugle, de conception hybride efficacité-mise en œuvre, pour évaluer la faisabilité des soins essentiels en cas d'AVC aigu dans des contextes à faibles ressources.

En savoir plus

EQUI-MEDS

Pression artérielle élevée 8 Team Members Spanning 5 countries

Le projet EQUI-MEDS vise à catalyser un débat mondial sur l'équivalence physico-chimique des médicaments génériques contre l'hypertension disponibles dans les points de vente au détail au Nigeria.

En savoir plus

FACTC

Tabac 7 Team Members Spanning 7 countries

The FACTc project aims to help policymakers establish sustainable mechanisms to fund and accelerate the comprehensive implementation of the WHO Framework Convention of Tobacco…

En savoir plus

GLO-PRO

Accès aux médicaments essentiels 9 Team Members Spanning 8 countries

The GLO-PRO project aims to conduct a situation analysis of policy processes for cardiovascular disease (CVD) essential medicines (ACE inhibitors, beta-blockers, statins & aspirin)…

En savoir plus

GOALPoST

Accident vasculaire cérébral 9 Team Members Spanning 8 countries

L'étude GOALPoST vise à établir des preuves solides de l'efficacité et de la sécurité des NOAC par rapport aux AVK dans la prévention des accidents vasculaires cérébraux dans le monde entier.

En savoir plus

HAVE-CVD-MeDs

Accès aux médicaments essentiels 7 Team Members Spanning 7 countries

HAVE CVD MeDs is an Emerging Leaders project focused on improving access to essential medicines for cardiovascular disease.

En savoir plus

IMPLEMENT CESSATION

Tabac 9 Team Members Spanning 6 countries

The Implement Cessation project aims to understand the facilitators and barriers to delivery of selected tobacco cessation interventions by healthcare providers in healthcare facilities…

En savoir plus

KOMPLY

Tabac 9 Team Members Spanning 8 countries

This project aims to communicate the level of compliance with the indoor 100% smoke-free law in bars and restaurants in Kampala, Uganda to the…

En savoir plus

PISCO

Pression artérielle élevée 8 Team Members Spanning 6 countries

The PISCO project aims to develop a dynamic online library of NCD policies and actions to coordinate and track progress towards 25×25 goals, with…

En savoir plus

REPs

Accident vasculaire cérébral 7 Team Members Spanning 6 countries

REPs would help in developing a white paper for China and India on strategies for harmonizing, developing and managing the rehabilitation workforce for not…

En savoir plus

TakeMeds

Prévention secondaire 9 Team Members Spanning 7 countries

The overarching goal of the TakeMeds program is to reduce the morbidity and mortality of cardiovascular disease (CVD) through the increased use of evidence-based, secondary-prevention…

En savoir plus

WikiMeds

Prévention secondaire 7 Team Members Spanning 5 countries

The WikiMeds project aims to evaluate the acceptability and feasibility of WikiMeds as a strategy for addressing the known barriers to the use of…

En savoir plus